Related Experiment Video
Updated: Oct 15, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Structural valve deterioration of the Labcor Dokimos aortic prosthesis: a single-centre experience
Dounia Iskandarani1, Omar Chaabo1, Walid Gharzeddine1
1Division of Cardiology, American University of Beirut Medical Center, Beirut, Lebanon.
Insights
The Labcor Dokimos bioprosthetic aortic valve shows a high incidence of structural valve deterioration (SVD), primarily due to aortic regurgitation. This early deterioration necessitates further investigation in larger patient cohorts.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Device Performance
Background:
- Bioprosthetic aortic valves are crucial for treating aortic valve disease.
- Assessing the long-term performance and durability of specific bioprosthetic valves is essential for clinical decision-making.
Purpose of the Study:
- To evaluate the performance and incidence of structural valve deterioration (SVD) in the Labcor Dokimos bioprosthetic aortic valve.
- To identify the primary causes and timing of SVD in this specific valve model.
Main Methods:
- Retrospective review of 116 patients undergoing surgical aortic valve replacement with the Labcor Dokimos valve (2010-2018).
- Analysis of patient demographics and echocardiographic data, categorizing patients into SVD and non-SVD groups.
- Final analysis included 85 patients with complete follow-up data.
Main Results:
- 38% (32/85) of patients developed SVD, with 26% (22/85) experiencing severe SVD.
- Severe central aortic regurgitation was the most common cause of SVD (91% of severe cases).
- The average time to severe SVD was 4.7 years.
Conclusions:
- The Labcor Dokimos bioprosthetic aortic valve demonstrates a high and early incidence of deterioration, predominantly linked to severe aortic regurgitation.
- These findings highlight the need for further investigation in larger registries to understand the long-term behavior of this valve.
- Early SVD impacts patient outcomes and may require timely reintervention.
Objectives:
The goal of this study was to assess the performance and incidence of the deterioration of the Labcor Dokimos bioprosthetic aortic valve.
Methods:
We performed a retrospective medical chart review of 116 patients who underwent surgical aortic valve replacement with the Labcor Dokimos aortic valve between 2010 and 2018. Abstracted data included patient demographic and echocardiographic data. Patients were divided into 2 groups: patients with structural valve deterioration (SVD) and patients without SVD.
Results:
Among the patients with complete follow-up (n = 95), 10 patients were excluded because they died within a year; 85 patients were included in the final analysis. Of the 85 patients, 32 (38%) developed SVD; 22 (26%) had severe SVD, 15 (18%) of whom underwent reintervention. The most common aetiology of SVD was severe central aortic regurgitation, which was detected in 91% of the patients who had severe SVD. The average time from operation to severe SVD was 4.7 years with a minimum of 1.5 years and a maximum of 7.9 years.
Conclusions:
Bioprosthetic aortic valve deterioration due to severe aortic regurgitation is common and occurs early with the Labcor Dokimos valve. This occurrence needs to be furthered investigated in larger registries.
More Related Videos
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management